Corient Private Wealth’s C4 Therapeutics CCCC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $18.2K | Sell |
12,695
-50
| -0.4% | -$72 | ﹤0.01% | 2506 |
|
|
2025
Q1 | $20.4K | Buy |
12,745
+50
| +0.4% | +$80 | ﹤0.01% | 2250 |
|
|
2024
Q4 | $45.7K | Hold |
12,695
| – | – | ﹤0.01% | 2279 |
|
|
2024
Q3 | $72.4K | Hold |
12,695
| – | – | ﹤0.01% | 2328 |
|
|
2024
Q2 | $58.7K | Hold |
12,695
| – | – | ﹤0.01% | 2241 |
|
|
2024
Q1 | $104K | Hold |
12,695
| – | – | ﹤0.01% | 2176 |
|
|
2023
Q4 | $71.7K | Hold |
12,695
| – | – | ﹤0.01% | 2175 |
|
|
2023
Q3 | $23.6K | Buy |
+12,695
| New | +$23.6K | ﹤0.01% | 2101 |
|
|
2023
Q2 | – | Sell |
-12,695
| Closed | -$39.9K | – | 2069 |
|
|
2023
Q1 | $39.9K | Buy |
12,695
+1,315
| +12% | +$4.13K | ﹤0.01% | 1938 |
|
|
2022
Q4 | $67.1K | Buy |
+11,380
| New | +$67.1K | ﹤0.01% | 1600 |
|